APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metronidazole

Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.

Selected research

Market Outlook & Growth Opportunities

Global Metronidazole Market Outlook and Growth Opportunities 2026

21 December 2025198 pages

Choose your research edition.

Industry ResearchMetronidazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Metronidazole Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Metronidazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metronidazole Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Metronidazole Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.

Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.

China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.

Read the full market overview

In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.

This report provides an overview of the global Metronidazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metronidazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metronidazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metronidazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Metronidazole Segment by Company

Hongyuan Pharmaceutical

Yinhe Aarti Pharmaceutical

Saikang Pharmaceutical

Zhongan Pharmaceutical

Wuyao Pharmaceutical

Yichang Changjiang Pharmaceutical

Tongji Pharmaceutical

Hongda Pharmaceutical

Topsun Pharmaceutical

Unichem Laboratories

CordenPharma Farchemia

API Polpharma

Manav Drugs

Aarey Drugs & Pharmaceuticals

Aarti Drugs

Metronidazole Segment by Type

Glyoxal Process

Ethidene Diamine Process

Others

Metronidazole Segment by Application

Metronidazole Tablets

Metronidazole Capsule

Metronidazole Injection

Others

Metronidazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Metronidazole status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Metronidazole market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Metronidazole significant trends, drivers, influence factors in global and regions.

6. To analyze Metronidazole competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metronidazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metronidazole market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metronidazole industry.

Chapter 3: Detailed analysis of Metronidazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Metronidazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Metronidazole in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Metronidazole Industry Trends Table 2. Metronidazole Industry Drivers Table 3. Metronidazole Industry Opportunities and Challenges Table 4. Metronidazole Industry Restraints Table 5. Global Metronidazole Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Metronidazole Revenue Share by Company (2021-2026) Table 7. Global Metronidazole Sales Volume by Company (MT) & (2021-2026) Table 8. Global Metronidazole Sales Volume Share by Company (2021-2026) Table 9. Global Metronidazole Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Metronidazole Company Ranking, (2024-2026) & (USD Million) Table 11. Global Metronidazole Key Company Manufacturing Base & Headquarters Table 12. Global Metronidazole Company, Product Type & Application Table 13. Global Metronidazole Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Metronidazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Glyoxal Process Table 18. Significant Companies of Ethidene Diamine Process Table 19. Significant Companies of Others Table 20. Global Metronidazole Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 21. Global Metronidazole Sales Volume by Type (2021-2026) & (MT) Table 22. Global Metronidazole Sales Volume by Type (2027-2032) & (MT) Table 23. Global Metronidazole Sales Volume Share by Type (2021-2026) Table 24. Global Metronidazole Sales Volume Share by Type (2027-2032) Table 25. Global Metronidazole Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Metronidazole Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Metronidazole Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Metronidazole Sales Value Share by Type (2021-2026) Table 29. Global Metronidazole Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Metronidazole Tablets Table 31. Significant Companies of Metronidazole Capsule Table 32. Significant Companies of Metronidazole Injection Table 33. Significant Companies of Others Table 34. Global Metronidazole Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 35. Global Metronidazole Sales Volume by Application (2021-2026) & (MT) Table 36. Global Metronidazole Sales Volume by Application (2027-2032) & (MT) Table 37. Global Metronidazole Sales Volume Share by Application (2021-2026) Table 38. Global Metronidazole Sales Volume Share by Application (2027-2032) Table 39. Global Metronidazole Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Metronidazole Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Metronidazole Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Metronidazole Sales Value Share by Application (2021-2026) Table 43. Global Metronidazole Sales Value Share by Application (2027-2032) Table 44. Global Metronidazole Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 45. Global Metronidazole Sales by Region (2021-2026) & (MT) Table 46. Global Metronidazole Sales Market Share by Region (2021-2026) Table 47. Global Metronidazole Sales by Region (2027-2032) & (MT) Table 48. Global Metronidazole Sales Market Share by Region (2027-2032) Table 49. Global Metronidazole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Metronidazole Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Metronidazole Sales Value Share by Region (2021-2026) Table 52. Global Metronidazole Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Metronidazole Sales Value Share by Region (2027-2032) Table 54. Global Metronidazole Market Average Price (USD/Kg) by Region (2021-2026) Table 55. Global Metronidazole Market Average Price (USD/Kg) by Region (2027-2032) Table 56. Global Metronidazole Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 57. Global Metronidazole Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Metronidazole Sales by Country (2021-2026) & (MT) Table 59. Global Metronidazole Sales Market Share by Country (2021-2026) Table 60. Global Metronidazole Sales by Country (2027-2032) & (MT) Table 61. Global Metronidazole Sales Market Share by Country (2027-2032) Table 62. Global Metronidazole Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Metronidazole Sales Value Market Share by Country (2021-2026) Table 64. Global Metronidazole Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Metronidazole Sales Value Market Share by Country (2027-2032) Table 66. Hongyuan Pharmaceutical Company Information Table 67. Hongyuan Pharmaceutical Business Overview Table 68. Hongyuan Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 69. Hongyuan Pharmaceutical Metronidazole Product Portfolio Table 70. Hongyuan Pharmaceutical Recent Development Table 71. Yinhe Aarti Pharmaceutical Company Information Table 72. Yinhe Aarti Pharmaceutical Business Overview Table 73. Yinhe Aarti Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Yinhe Aarti Pharmaceutical Metronidazole Product Portfolio Table 75. Yinhe Aarti Pharmaceutical Recent Development Table 76. Saikang Pharmaceutical Company Information Table 77. Saikang Pharmaceutical Business Overview Table 78. Saikang Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Saikang Pharmaceutical Metronidazole Product Portfolio Table 80. Saikang Pharmaceutical Recent Development Table 81. Zhongan Pharmaceutical Company Information Table 82. Zhongan Pharmaceutical Business Overview Table 83. Zhongan Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Zhongan Pharmaceutical Metronidazole Product Portfolio Table 85. Zhongan Pharmaceutical Recent Development Table 86. Wuyao Pharmaceutical Company Information Table 87. Wuyao Pharmaceutical Business Overview Table 88. Wuyao Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Wuyao Pharmaceutical Metronidazole Product Portfolio Table 90. Wuyao Pharmaceutical Recent Development Table 91. Yichang Changjiang Pharmaceutical Company Information Table 92. Yichang Changjiang Pharmaceutical Business Overview Table 93. Yichang Changjiang Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Yichang Changjiang Pharmaceutical Metronidazole Product Portfolio Table 95. Yichang Changjiang Pharmaceutical Recent Development Table 96. Tongji Pharmaceutical Company Information Table 97. Tongji Pharmaceutical Business Overview Table 98. Tongji Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Tongji Pharmaceutical Metronidazole Product Portfolio Table 100. Tongji Pharmaceutical Recent Development Table 101. Hongda Pharmaceutical Company Information Table 102. Hongda Pharmaceutical Business Overview Table 103. Hongda Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Hongda Pharmaceutical Metronidazole Product Portfolio Table 105. Hongda Pharmaceutical Recent Development Table 106. Topsun Pharmaceutical Company Information Table 107. Topsun Pharmaceutical Business Overview Table 108. Topsun Pharmaceutical Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Topsun Pharmaceutical Metronidazole Product Portfolio Table 110. Topsun Pharmaceutical Recent Development Table 111. Unichem Laboratories Company Information Table 112. Unichem Laboratories Business Overview Table 113. Unichem Laboratories Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Unichem Laboratories Metronidazole Product Portfolio Table 115. Unichem Laboratories Recent Development Table 116. CordenPharma Farchemia Company Information Table 117. CordenPharma Farchemia Business Overview Table 118. CordenPharma Farchemia Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. CordenPharma Farchemia Metronidazole Product Portfolio Table 120. CordenPharma Farchemia Recent Development Table 121. API Polpharma Company Information Table 122. API Polpharma Business Overview Table 123. API Polpharma Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. API Polpharma Metronidazole Product Portfolio Table 125. API Polpharma Recent Development Table 126. Manav Drugs Company Information Table 127. Manav Drugs Business Overview Table 128. Manav Drugs Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 129. Manav Drugs Metronidazole Product Portfolio Table 130. Manav Drugs Recent Development Table 131. Aarey Drugs & Pharmaceuticals Company Information Table 132. Aarey Drugs & Pharmaceuticals Business Overview Table 133. Aarey Drugs & Pharmaceuticals Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 134. Aarey Drugs & Pharmaceuticals Metronidazole Product Portfolio Table 135. Aarey Drugs & Pharmaceuticals Recent Development Table 136. Aarti Drugs Company Information Table 137. Aarti Drugs Business Overview Table 138. Aarti Drugs Metronidazole Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 139. Aarti Drugs Metronidazole Product Portfolio Table 140. Aarti Drugs Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Metronidazole Distributors List Table 144. Metronidazole Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Metronidazole Product Image Figure 2. Global Metronidazole Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metronidazole Sales Value (2021-2032) & (US$ Million) Figure 4. Global Metronidazole Sales (2021-2032) & (MT) Figure 5. Global Metronidazole Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Metronidazole Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Glyoxal Process Image Figure 10. Ethidene Diamine Process Image Figure 11. Others Image Figure 12. Global Metronidazole Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 13. Global Metronidazole Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Metronidazole Sales Volume Share by Type (2021-2032) Figure 15. Global Metronidazole Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Metronidazole Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Metronidazole Sales Value Share by Type (2021-2032) Figure 18. Metronidazole Tablets Image Figure 19. Metronidazole Capsule Image Figure 20. Metronidazole Injection Image Figure 21. Others Image Figure 22. Global Metronidazole Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global Metronidazole Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Metronidazole Sales Volume Share by Application (2021-2032) Figure 25. Global Metronidazole Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Metronidazole Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Metronidazole Sales Value Share by Application (2021-2032) Figure 28. Global Metronidazole Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 29. Global Metronidazole Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Metronidazole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Metronidazole Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Metronidazole Sales Value (2021-2032) & (US$ Million) Figure 33. North America Metronidazole Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Metronidazole Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Metronidazole Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Metronidazole Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Metronidazole Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Metronidazole Sales Value (2021-2032) & (US$ Million) Figure 39. South America Metronidazole Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Metronidazole Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Metronidazole Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Metronidazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Metronidazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Metronidazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Metronidazole Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Metronidazole Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Glyoxal Process
  • Ethidene Diamine Process
  • Others
Applications
  • Metronidazole Tablets
  • Metronidazole Capsule
  • Metronidazole Injection
  • Others
Companies covered
  • Hongyuan Pharmaceutical
  • Yinhe Aarti Pharmaceutical
  • Saikang Pharmaceutical
  • Zhongan Pharmaceutical
  • Wuyao Pharmaceutical
  • Yichang Changjiang Pharmaceutical
  • Tongji Pharmaceutical
  • Hongda Pharmaceutical
  • Topsun Pharmaceutical
  • Unichem Laboratories
  • CordenPharma Farchemia
  • API Polpharma
  • Manav Drugs
  • Aarey Drugs & Pharmaceuticals
  • Aarti Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metronidazole Sales Value (2021-2032)
  4. 1.2.2 Global Metronidazole Sales Volume (2021-2032)
  5. 1.2.3 Global Metronidazole Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Metronidazole Market Dynamics
  1. 2.1 Metronidazole Industry Trends
  2. 2.2 Metronidazole Industry Drivers
  3. 2.3 Metronidazole Industry Opportunities and Challenges
  4. 2.4 Metronidazole Industry Restraints
3 Metronidazole Market by Company
  1. 3.1 Global Metronidazole Company Revenue Ranking in 2025
  2. 3.2 Global Metronidazole Revenue by Company (2021-2026)
  3. 3.3 Global Metronidazole Sales Volume by Company (2021-2026)
  4. 3.4 Global Metronidazole Average Price by Company (2021-2026)
  5. 3.5 Global Metronidazole Company Ranking (2024-2026)
  6. 3.6 Global Metronidazole Company Manufacturing Base and Headquarters
  7. 3.7 Global Metronidazole Company Product Type and Application
  8. 3.8 Global Metronidazole Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Metronidazole Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Metronidazole Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Metronidazole Market by Type
  1. 4.1 Metronidazole Type Introduction
  2. 4.1.1 Glyoxal Process
  3. 4.1.2 Ethidene Diamine Process
  4. 4.1.3 Others
  5. 4.2 Global Metronidazole Sales Volume by Type
  6. 4.2.1 Global Metronidazole Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Metronidazole Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Metronidazole Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Metronidazole Sales Value by Type
  10. 4.3.1 Global Metronidazole Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Metronidazole Sales Value by Type (2021-2032)
  12. 4.3.3 Global Metronidazole Sales Value Share by Type (2021-2032)
5 Metronidazole Market by Application
  1. 5.1 Metronidazole Application Introduction
  2. 5.1.1 Metronidazole Tablets
  3. 5.1.2 Metronidazole Capsule
  4. 5.1.3 Metronidazole Injection
  5. 5.1.4 Others
  6. 5.2 Global Metronidazole Sales Volume by Application
  7. 5.2.1 Global Metronidazole Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Metronidazole Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Metronidazole Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Metronidazole Sales Value by Application
  11. 5.3.1 Global Metronidazole Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Metronidazole Sales Value by Application (2021-2032)
  13. 5.3.3 Global Metronidazole Sales Value Share by Application (2021-2032)
6 Metronidazole Regional Sales and Value Analysis
  1. 6.1 Global Metronidazole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metronidazole Sales by Region (2021-2032)
  3. 6.2.1 Global Metronidazole Sales by Region: 2021-2026
  4. 6.2.2 Global Metronidazole Sales by Region (2027-2032)
  5. 6.3 Global Metronidazole Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Metronidazole Sales Value by Region (2021-2032)
  7. 6.4.1 Global Metronidazole Sales Value by Region: 2021-2026
  8. 6.4.2 Global Metronidazole Sales Value by Region (2027-2032)
  9. 6.5 Global Metronidazole Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Metronidazole Sales Value (2021-2032)
  12. 6.6.2 North America Metronidazole Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Metronidazole Sales Value (2021-2032)
  15. 6.7.2 Europe Metronidazole Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Metronidazole Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Metronidazole Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Metronidazole Sales Value (2021-2032)
  21. 6.9.2 South America Metronidazole Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Metronidazole Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Metronidazole Sales Value Share by Country, 2025 VS 2032
7 Metronidazole Country-level Sales and Value Analysis
  1. 7.1 Global Metronidazole Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Metronidazole Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Metronidazole Sales by Country (2021-2032)
  4. 7.3.1 Global Metronidazole Sales by Country (2021-2026)
  5. 7.3.2 Global Metronidazole Sales by Country (2027-2032)
  6. 7.4 Global Metronidazole Sales Value by Country (2021-2032)
  7. 7.4.1 Global Metronidazole Sales Value by Country (2021-2026)
  8. 7.4.2 Global Metronidazole Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Metronidazole Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Metronidazole Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Metronidazole Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Metronidazole Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Metronidazole Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Metronidazole Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Metronidazole Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Metronidazole Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Metronidazole Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Metronidazole Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Metronidazole Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Metronidazole Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Metronidazole Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Metronidazole Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Metronidazole Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Metronidazole Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Metronidazole Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Metronidazole Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Metronidazole Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Metronidazole Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Metronidazole Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Metronidazole Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Metronidazole Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Metronidazole Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Metronidazole Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Metronidazole Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Metronidazole Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Metronidazole Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Metronidazole Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Metronidazole Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Metronidazole Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Metronidazole Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Metronidazole Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Metronidazole Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Metronidazole Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Metronidazole Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Metronidazole Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Metronidazole Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Metronidazole Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Metronidazole Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Metronidazole Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Metronidazole Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Metronidazole Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Metronidazole Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Metronidazole Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Metronidazole Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Metronidazole Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Metronidazole Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Metronidazole Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Metronidazole Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Metronidazole Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Metronidazole Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Metronidazole Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Metronidazole Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Metronidazole Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Metronidazole Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Metronidazole Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Metronidazole Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Metronidazole Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Metronidazole Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Metronidazole Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Metronidazole Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Metronidazole Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Metronidazole Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Metronidazole Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Metronidazole Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Metronidazole Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Metronidazole Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Metronidazole Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Metronidazole Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Metronidazole Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Metronidazole Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Metronidazole Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Metronidazole Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Metronidazole Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Metronidazole Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Metronidazole Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Metronidazole Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Metronidazole Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Metronidazole Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Metronidazole Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Metronidazole Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Metronidazole Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Metronidazole Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hongyuan Pharmaceutical
  2. 8.1.1 Hongyuan Pharmaceutical Company Information
  3. 8.1.2 Hongyuan Pharmaceutical Business Overview
  4. 8.1.3 Hongyuan Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hongyuan Pharmaceutical Metronidazole Product Portfolio
  6. 8.1.5 Hongyuan Pharmaceutical Recent Developments
  7. 8.2 Yinhe Aarti Pharmaceutical
  8. 8.2.1 Yinhe Aarti Pharmaceutical Company Information
  9. 8.2.2 Yinhe Aarti Pharmaceutical Business Overview
  10. 8.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yinhe Aarti Pharmaceutical Metronidazole Product Portfolio
  12. 8.2.5 Yinhe Aarti Pharmaceutical Recent Developments
  13. 8.3 Saikang Pharmaceutical
  14. 8.3.1 Saikang Pharmaceutical Company Information
  15. 8.3.2 Saikang Pharmaceutical Business Overview
  16. 8.3.3 Saikang Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Saikang Pharmaceutical Metronidazole Product Portfolio
  18. 8.3.5 Saikang Pharmaceutical Recent Developments
  19. 8.4 Zhongan Pharmaceutical
  20. 8.4.1 Zhongan Pharmaceutical Company Information
  21. 8.4.2 Zhongan Pharmaceutical Business Overview
  22. 8.4.3 Zhongan Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zhongan Pharmaceutical Metronidazole Product Portfolio
  24. 8.4.5 Zhongan Pharmaceutical Recent Developments
  25. 8.5 Wuyao Pharmaceutical
  26. 8.5.1 Wuyao Pharmaceutical Company Information
  27. 8.5.2 Wuyao Pharmaceutical Business Overview
  28. 8.5.3 Wuyao Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wuyao Pharmaceutical Metronidazole Product Portfolio
  30. 8.5.5 Wuyao Pharmaceutical Recent Developments
  31. 8.6 Yichang Changjiang Pharmaceutical
  32. 8.6.1 Yichang Changjiang Pharmaceutical Company Information
  33. 8.6.2 Yichang Changjiang Pharmaceutical Business Overview
  34. 8.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Yichang Changjiang Pharmaceutical Metronidazole Product Portfolio
  36. 8.6.5 Yichang Changjiang Pharmaceutical Recent Developments
  37. 8.7 Tongji Pharmaceutical
  38. 8.7.1 Tongji Pharmaceutical Company Information
  39. 8.7.2 Tongji Pharmaceutical Business Overview
  40. 8.7.3 Tongji Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tongji Pharmaceutical Metronidazole Product Portfolio
  42. 8.7.5 Tongji Pharmaceutical Recent Developments
  43. 8.8 Hongda Pharmaceutical
  44. 8.8.1 Hongda Pharmaceutical Company Information
  45. 8.8.2 Hongda Pharmaceutical Business Overview
  46. 8.8.3 Hongda Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hongda Pharmaceutical Metronidazole Product Portfolio
  48. 8.8.5 Hongda Pharmaceutical Recent Developments
  49. 8.9 Topsun Pharmaceutical
  50. 8.9.1 Topsun Pharmaceutical Company Information
  51. 8.9.2 Topsun Pharmaceutical Business Overview
  52. 8.9.3 Topsun Pharmaceutical Metronidazole Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Topsun Pharmaceutical Metronidazole Product Portfolio
  54. 8.9.5 Topsun Pharmaceutical Recent Developments
  55. 8.10 Unichem Laboratories
  56. 8.10.1 Unichem Laboratories Company Information
  57. 8.10.2 Unichem Laboratories Business Overview
  58. 8.10.3 Unichem Laboratories Metronidazole Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Unichem Laboratories Metronidazole Product Portfolio
  60. 8.10.5 Unichem Laboratories Recent Developments
  61. 8.11 CordenPharma Farchemia
  62. 8.11.1 CordenPharma Farchemia Company Information
  63. 8.11.2 CordenPharma Farchemia Business Overview
  64. 8.11.3 CordenPharma Farchemia Metronidazole Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CordenPharma Farchemia Metronidazole Product Portfolio
  66. 8.11.5 CordenPharma Farchemia Recent Developments
  67. 8.12 API Polpharma
  68. 8.12.1 API Polpharma Company Information
  69. 8.12.2 API Polpharma Business Overview
  70. 8.12.3 API Polpharma Metronidazole Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 API Polpharma Metronidazole Product Portfolio
  72. 8.12.5 API Polpharma Recent Developments
  73. 8.13 Manav Drugs
  74. 8.13.1 Manav Drugs Company Information
  75. 8.13.2 Manav Drugs Business Overview
  76. 8.13.3 Manav Drugs Metronidazole Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Manav Drugs Metronidazole Product Portfolio
  78. 8.13.5 Manav Drugs Recent Developments
  79. 8.14 Aarey Drugs & Pharmaceuticals
  80. 8.14.1 Aarey Drugs & Pharmaceuticals Company Information
  81. 8.14.2 Aarey Drugs & Pharmaceuticals Business Overview
  82. 8.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Product Portfolio
  84. 8.14.5 Aarey Drugs & Pharmaceuticals Recent Developments
  85. 8.15 Aarti Drugs
  86. 8.15.1 Aarti Drugs Company Information
  87. 8.15.2 Aarti Drugs Business Overview
  88. 8.15.3 Aarti Drugs Metronidazole Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Aarti Drugs Metronidazole Product Portfolio
  90. 8.15.5 Aarti Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metronidazole Value Chain Analysis
  2. 9.1.1 Metronidazole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metronidazole Sales Mode & Process
  6. 9.2 Metronidazole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metronidazole Distributors
  9. 9.2.3 Metronidazole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst